MHE Staff

One code covers additional supplies and clinical time related to safety protocols. The other covers antibody testing.

The letter, “Dentists Fighting Covid” states, in part: “We believe your recommendation is irresponsible, unsubstantiated and dead wrong."

Four initiatives healthcare operators can implement to help their employees deal with the challenges posed by the pandemic.

Pro, college, and high school athletes are seeing increasing numbers of COVID-19 infection and potential heart complications that could be career-ending. Ambulatory cardiac monitoring provider InfoBionic says simple and effective remote cardiac monitoring will save lives—and careers.

A JAMA Oncology viewpoint argues that the COVID-19 pandemic presents a prime opportunity to make clinical trial design and execution more efficient.

Findings presented at the European Society of Cardiology meeting could open the door to the use of the gout drug as a treatment targeting the underlying inflammation of cardiovascular disease.

This week's FDA updates include an end to a boxed warning for a type 2 diabetes drug, an expanded emergency use authorization due to COVID-19, and another liquid biopsy.

Integrated Benefits Institute study finds increased screenings for depression and detection of chronic conditions before symptoms present could have greatest impact on disability costs.

Scientists react negatively to FDA's handling of the Emergency Use Authorization for convalescent plasma in COVID-19.

FDA actions for the week ending August 21, 2020, include a hearing set for a drug that could limit weight gain often associated with treatment for serious mental illness.

Survey of Midwestern ophthalmologists identifies reasons for wariness of generics.

As the American population ages, chronic conditions are becoming an increasing challenge for payers. In addition to conditions such as cardiovascular disease and diabetes, eye disease is also prevalent among aging adults.

Almost four million people miss their medical appointments every year due to a lack of reliable transportation. To address this challenge, Lyft has been working with healthcare organizations since 2016 to get patients in need to and from their medical appointments.

There are several explanations for the growing number of nearsightedness people.Time spent looking at computer and cellphone screens has been identified as a culprit.

Expert William J. Mallon, M.D., discusses the most-common eye diseases seen in practice.

Authors of a review say biosimilars would improve treatment, not just reduce cost.

Real-world evidence from 67 patients recently found benefits for those with diabetic macular edema who switched to Eylea from Lucentis.

Whether the OCM has worked out is debatable, but it has apparently encouraged the use of biosimilar versions of filgrastim.

Actions from FDA this week include approval of a second targted treatment for a Duchenne muscular dystrophy mutation, and filings in COVID-19 and blood disorders.

The physician-led communication training program is now available through a virtual-only experience as health care organizations adapt to the changing environment surrounding COVID-19.

Botco.ai’s AI-powered intelligent chat solution automatically addresses questions regarding COVID-19, scheduling visits, franchising and more.

Researchers reviewed the evidence of the association between vitamin D and multiple sclerosis.

A recent study found 64% of patients with psoriatic arthritis who had tried at least one biologic stayed with Cosentyx for the entire study period.

Dovato lets adults with HIV reduce the number of antiretroviral therapies they take, while maintaining efficacy and a high barrier to resistance comparable to tenofovir-based regimens.

Double-blind study will compare Rebif-remdesivir combination with remdesivir-alone in hospitalized COVID-19 patients

The highly respected healthcare industry veteran will bring his signature team building skills, track record of double-digit revenue growth and subject matter expertise in diabetes.

Many are anxious or down but finding silver linings amidst challenges; essential workers and boomers are faring better than most.